Epigallocatechin gallate (EGCG), a FASN inhibitor extracted from green tea [215], reduced cell proliferation, ATP production, and AKT activity in trastuzumab-resistant HER2+ BC cells. This evidence concerns the gene ERBB2 and breast cancer.